Biovest International, Inc. is an emerging leader in the field of active personalized immunotherapies.  Headquartered in Tampa, Florida with its bio-manufacturing facility based in Minneapolis, Minnesota, Biovest is publicly-traded on the OTCQB™ Market with the stock-ticker symbol “BVTI”, and is a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: “ABPI”).

Frequently Asked Questions:

What Exchange is Biovest traded on?
Biovest trades on the OTCQB, a market tier for OTC-traded U.S. companies that are registered and reporting with the SEC. Investors can view real-time stock quotes at: http://www.otcmarkets.com

Who is Biovest’s transfer agent?
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY  11219
Phone: 800-937-5449
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Website: www.amstock.com

When does Biovest’s fiscal year end?
Biovest’s fiscal year ends on September 30th.

Who is Biovest’s independent registered public accounting firm?
Cherry, Bekaert & Holland L.L.P.
Website: http://www.cbh.com

What equity research analysts are currently covering Biovest?
> ROTH Capital Partners, Joseph Pantginis Ph.D.

How can I sign-up to receive Biovest’s press releases?
Please visit the “Contact Us” section of our website to request to be added to Biovest’s news distribution list.

Who can I speak with regarding my specific questions?
Please call Doug Calder at 813-864-2558 or email him at This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Is there a FAQ document covering BiovaxID?
Yes; please click here for Frequently Asked Questions on BiovaxID.